Herbert W. Virgin

(Redirected from Herbert Virgin IV)

Herbert W. "Skip" Virgin was the Edward Mallinckrodt Professor and Chair of the Department of Pathology & Immunology at the Washington University School of Medicine[1] and a member of the National Academy of Sciences.[2] He is best known for establishing murine norovirus as a model system for studying norovirus biology, for identifying host phenotypes associated with persistent viral infections, for defining alterations to the human virome in the context of different diseases, and for elucidating the roles of autophagy and interferon-stimulated genes during viral infection.

Herbert W. "Skip" Virgin
Born
Alma mater
Known for
Scientific career
Fields
Institutions
Doctoral advisor

Life

edit

Herbert Virgin was born in Miami, Florida and studied biology at Harvard University as an undergraduate, graduating magna cum laude. He obtained his M.D. and Ph.D. from Harvard Medical School, with his thesis work focusing on host immune responses to Listeria monocytogenes, and completed his residency in internal medicine at Brigham and Women's Hospital.[3] Following post-doctoral training in the laboratory of Bernard Fields, he joined the faculty of the Washington University School of Medicine. He remained at Washington University until 2018, most recently as Chair of the Department of Pathology & Immunology. Virgin left St. Louis to enter the biomedical industrial sector, and was succeeded as chairman by Richard J. Cote.

Selected publications

edit
  • Barton, E; White, D; Cathelyn, J; Brett-McClellan, K; Engle, M; Diamond, M; Miller, V; Virgin, H (2007). "Herpesvirus latency confers symbiotic protection from bacterial infection". Nature. 447 (7142): 326–329. Bibcode:2007Natur.447..326B. doi:10.1038/nature05762. PMID 17507983. S2CID 4425405.
  • Nice, T; Baldridge, M; McCune, B; Norman, J; Lazear, H; Artyomov, M; Diamond, M; Virgin, H (2015). "Interferon λ cures persistent murine norovirus infection in the absence of adaptive immunity". Science. 347 (6219): 269–273. Bibcode:2015Sci...347..269N. doi:10.1126/science.1258100. PMC 4398891. PMID 25431489.
  • Orchard, R; Wilen, C; Doench, J; Baldridge, M; McCune, B; Lee, Y; Lee, S; Pruett-Miller, S; Nelson, C; Fremont, D; Virgin, H (2016). "Discovery of a proteinaceous cellular receptor for a norovirus". Science. 26 (6302): 933–936. Bibcode:2016Sci...353..933O. doi:10.1126/science.aaf1220. PMC 5484048. PMID 27540007.
  • Norman, J; Handley, S; Baldridge, M; Droit, L; Liu, C; Keller, B; Kambal, A; Monaco, C; Zhao, G; Fleshner, P; Stappenbeck, T; McGovern, D; Keshavarzian, A; Mutlu, E; Sauk, J; Gevers, D; Xavier, R; Wang, D; Parkes, M; Virgin, H (2015). "Disease-specific alterations in the enteric viriome in inflammatory bowel disease". Cell. 160 (3): 447–460. doi:10.1016/j.cell.2015.01.002. PMC 4312520. PMID 25619688.

References

edit
  1. ^ "Herbert Virgin IV, MD, PhD". Washington University School of Medicine. Retrieved 2016-12-31.
  2. ^ "Herbert W. Virgin, IV". National Academy of Sciences. Retrieved 2016-12-31.
  3. ^ "Herbert Virgin, M.D., Ph.D." mBio Board of Editors. Retrieved 2016-12-31.